Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.3 USD | +5.15% | +2.77% | +37.27% |
05-09 | Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating | MT |
05-08 | Revolution Medicines Q1 Net Loss Narrows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.27% | 6.17B | |
+28.88% | 49.18B | |
+0.86% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.18% | 18.71B | |
+7.85% | 13.26B | |
+32.41% | 12.32B | |
-0.63% | 11.99B |
- Stock Market
- Equities
- RVMD Stock
- News Revolution Medicines, Inc.
- Stifel Raises Revolution Medicines' Price Target to $47 From $37, Keeps Buy Rating